REPERTOIRE
Cogen Immune Medicine, Inc.
Application Filed: 2020-01-27
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88774013 |
| Registration Number | 6303018 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | V03112001000 |
Timeline
| 2020-01-27 | Application Filed |
| 2020-01-30 | Location: NEW APPLICATION PROCESSING |
| 2020-01-30 | Status: Live/Pending |
| 2020-01-30 | Transaction Date |
| 2021-03-23 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Cogen Immune Medicine, Inc. |
| Address | 26 Landsdowne Street Cambridge DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Chemical agents for scientific and research use used for modulating an immune response; Therapeutic products for medical purposes in the nature of biological preparations, biological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations; Pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells |
| GS0051 | therapeutic products for medical purposes in the nature of biological preparations, biological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations used to modulate an immune response; pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations in the nature of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-01-30 | 1 NWOS I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-04-08 | 2 ASGN I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-04-15 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-04-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-04-21 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-04-21 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-07-14 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-07-14 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-07-15 | 9 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2020-08-03 | 10 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2020-08-03 | 11 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-08-03 | 12 GNFN O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2021-02-03 | 13 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2021-02-03 | 14 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2021-02-03 | 15 EXPI T:TTAB Proceeding |
| TEAS AMENDMENT OF USE RECEIVED | 2021-02-03 | 16 EAAU I:Incoming Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2021-02-03 | 17 ERFR I:Incoming Correspondence |
| USE AMENDMENT FILED | 2021-02-04 | 18 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2021-02-04 | 19 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2021-02-11 | 20 IUAA P: |
| EXAMINERS AMENDMENT -WRITTEN | 2021-02-11 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-02-11 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-02-11 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-02-11 | 24 XAEC I:Incoming Correspondence |
| APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2021-02-11 | 25 CNTA O:Outgoing Correspondence |
| EXPARTE APPEAL TERMINATED | 2021-02-11 | 26 EXPT T:TTAB Proceeding |
| ASSIGNED TO LIE | 2021-02-11 | 27 ALIE A:Allowance for Publication |
| NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2021-02-12 | 28 AAUA E:E-Mail |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2021-02-12 | 29 PREV O:Outgoing Correspondence |
| REGISTERED-SUPPLEMENTAL REGISTER | 2021-03-23 | 30 R.SR A:Allowance for Publication |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 